
Sign up to save your podcasts
Or


Now, the American Gastroenterological Association (AGA) has published a “Rapid Clinical Practice Update,”
note that evidence is insufficient to make strong recommendations about continuing or withholding GLP-1 agonists prior to endoscopy. The AGA suggests an individualized approach: GLP-1 agonists “could be withheld” in patients who take the drugs solely for obesity, but the authors worry that omitting a dose in a patient with diabetes might confer more risk than benefit.
They say the scope should go on as long as the pt has been on an 8 hour solid fast and a 2 hour liquid fast
https://www.sciencedirect.com/science/article/pii/S1542356523008698?via%3Dihub
By Questioning Medicine4.9
7474 ratings
Now, the American Gastroenterological Association (AGA) has published a “Rapid Clinical Practice Update,”
note that evidence is insufficient to make strong recommendations about continuing or withholding GLP-1 agonists prior to endoscopy. The AGA suggests an individualized approach: GLP-1 agonists “could be withheld” in patients who take the drugs solely for obesity, but the authors worry that omitting a dose in a patient with diabetes might confer more risk than benefit.
They say the scope should go on as long as the pt has been on an 8 hour solid fast and a 2 hour liquid fast
https://www.sciencedirect.com/science/article/pii/S1542356523008698?via%3Dihub

7,586 Listeners

14,816 Listeners

136 Listeners

700 Listeners

497 Listeners

259 Listeners

2,446 Listeners

3,337 Listeners

56,500 Listeners

1,151 Listeners

28,406 Listeners

6,396 Listeners

372 Listeners

29,188 Listeners

1,308 Listeners